{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:47:27Z","timestamp":1790624847519,"version":"4.1.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T00:00:00Z","timestamp":1572220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T00:00:00Z","timestamp":1572220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1UG3 HL-147366-01"],"award-info":[{"award-number":["1UG3 HL-147366-01"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["P01 HL-51670"],"award-info":[{"award-number":["P01 HL-51670"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["P01 HL-091842"],"award-info":[{"award-number":["P01 HL-091842"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute"},{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30 DK-54759"],"award-info":[{"award-number":["P30 DK-54759"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["MCCRAY15XX0"],"award-info":[{"award-number":["MCCRAY15XX0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001024","name":"Roy J. Carver Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The delivery of biologic cargoes to airway epithelial cells is challenging due to the formidable barriers imposed by its specialized and differentiated cells. Among cargoes, recombinant proteins offer therapeutic promise but the lack of effective delivery methods limits their development. Here, we achieve protein and SpCas9 or AsCas12a ribonucleoprotein (RNP) delivery to cultured human well-differentiated airway epithelial cells and mouse lungs with engineered amphiphilic peptides. These shuttle peptides, non-covalently combined with GFP protein or CRISPR-associated nuclease (Cas) RNP, allow rapid entry into cultured human ciliated and non-ciliated epithelial cells and mouse airway epithelia. Instillation of shuttle peptides combined with SpCas9 or AsCas12a RNP achieves editing of <jats:italic>loxP<\/jats:italic> sites in airway epithelia of ROSA<jats:sup>mT\/mG<\/jats:sup> mice. We observe no evidence of short-term toxicity with a widespread distribution restricted to the respiratory tract. This peptide-based technology advances potential therapeutic avenues for protein and Cas RNP delivery to refractory airway epithelial cells.<\/jats:p>","DOI":"10.1038\/s41467-019-12922-y","type":"journal-article","created":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T11:34:00Z","timestamp":1572262440000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":124,"title":["Engineered amphiphilic peptides enable delivery of proteins and CRISPR-associated nucleases to airway epithelia"],"prefix":"10.1038","volume":"10","author":[{"given":"Sateesh","family":"Krishnamurthy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Wohlford-Lenane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhas","family":"Kandimalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Sartre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1552-3253","authenticated-orcid":false,"given":"David K.","family":"Meyerholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Th\u00e9berge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Hall\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Duperr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4969-7016","authenticated-orcid":false,"given":"Thomas","family":"Del\u2019Guidice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pascal","family":"Lepetit-Stoffaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Barbeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Guay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4067-577X","authenticated-orcid":false,"suffix":"Jr.","given":"Paul B.","family":"McCray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,28]]},"reference":[{"key":"12922_CR1","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1183\/09031936.00141514","volume":"45","author":"PS Hiemstra","year":"2015","unstructured":"Hiemstra, P. S., McCray, P. B. Jr. & Bals, R. The innate immune function of airway epithelial cells in inflammatory lung disease. Eur. Respir. J. 45, 1150\u20131162 (2015).","journal-title":"Eur. Respir. J."},{"key":"12922_CR2","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/S0140-6736(98)06532-5","volume":"353","author":"EW Alton","year":"1999","unstructured":"Alton, E. W. et al. Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet 353, 947\u2013954 (1999).","journal-title":"Lancet"},{"key":"12922_CR3","doi-asserted-by":"publisher","first-page":"e88728","DOI":"10.1172\/jci.insight.88728","volume":"1","author":"B Steines","year":"2016","unstructured":"Steines, B. et al. CFTR gene transfer with AAV improves early cystic fibrosis pig phenotypes. JCI Insight 1, e88728 (2016).","journal-title":"JCI Insight"},{"key":"12922_CR4","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1073\/pnas.0813365106","volume":"106","author":"KJ Excoffon","year":"2009","unstructured":"Excoffon, K. J. et al. Directed evolution of adeno-associated virus to an infectious respiratory virus. Proc. Natl Acad. Sci. USA 106, 3865\u20133870 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"12922_CR5","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/mt.2014.89","volume":"22","author":"BS Schuster","year":"2014","unstructured":"Schuster, B. S. et al. Overcoming the cystic fibrosis sputum barrier to leading adeno-associated virus gene therapy vectors. Mol. Ther. 22, 1484\u20131493 (2014).","journal-title":"Mol. Ther."},{"key":"12922_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1136\/thoraxjnl-2016-208406","volume":"72","author":"EW Alton","year":"2017","unstructured":"Alton, E. W. et al. Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis. Thorax 72, 137\u2013147 (2017).","journal-title":"Thorax"},{"key":"12922_CR7","doi-asserted-by":"publisher","first-page":"9591","DOI":"10.1093\/nar\/gky773","volume":"46","author":"AL Cooney","year":"2018","unstructured":"Cooney, A. L. et al. Widespread airway distribution and short-term phenotypic correction of cystic fibrosis pigs following aerosol delivery of piggyBac\/adenovirus. Nucleic Acids Res. 46, 9591\u20139600 (2018).","journal-title":"Nucleic Acids Res."},{"key":"12922_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1465-9921-7-26","volume":"7","author":"U Griesenbach","year":"2006","unstructured":"Griesenbach, U. et al. Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo. Respir. Res. 7, 26 (2006).","journal-title":"Respir. Res."},{"key":"12922_CR9","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/sj.gt.3300840","volume":"6","author":"C Kitson","year":"1999","unstructured":"Kitson, C. et al. The extra- and intracellular barriers to lipid and adenovirus-mediated pulmonary gene transfer in native sheep airway epithelium. Gene Ther. 6, 534\u2013546 (1999).","journal-title":"Gene Ther."},{"issue":"1","key":"12922_CR10","doi-asserted-by":"publisher","first-page":"L23","DOI":"10.1152\/ajplung.00426.2012","volume":"305","author":"Shyam Ramachandran","year":"2013","unstructured":"Ramachandran, S. et al. Efficient delivery of RNA-interference oligonucleotides to polarized airway epithelia in vitro. Am. J. Physiol. Lung Cell. Mol. Physiol. 305, L23\u2013L32 (2013).","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"key":"12922_CR11","doi-asserted-by":"publisher","first-page":"18997","DOI":"10.1074\/jbc.270.32.18997","volume":"270","author":"J Zabner","year":"1995","unstructured":"Zabner, J., Fasbender, A. J., Moninger, T., Poellinger, K. A. & Welsh, M. J. Cellular and molecular barriers to gene transfer by a cationic lipid. J. Biol. Chem. 270, 18997\u201319007 (1995).","journal-title":"J. Biol. Chem."},{"key":"12922_CR12","doi-asserted-by":"publisher","first-page":"10219","DOI":"10.1074\/jbc.274.15.10219","volume":"274","author":"RW Walters","year":"1999","unstructured":"Walters, R. W. et al. Basolateral localization of fiber receptors limits adenovirus infection of airway epithelia. J. Biol. Chem. 274, 10219\u201310226 (1999).","journal-title":"J. Biol. Chem."},{"key":"12922_CR13","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.3389\/fphar.2018.01208","volume":"9","author":"TA Slastnikova","year":"2018","unstructured":"Slastnikova, T. A., Ulasov, A. V., Rosenkranz, A. A. & Sobolev, A. S. Targeted intracellular delivery of antibodies: the state of the art. Front Pharm. 9, 1208 (2018).","journal-title":"Front Pharm."},{"key":"12922_CR14","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.biomaterials.2012.08.070","volume":"34","author":"CY Dombu","year":"2013","unstructured":"Dombu, C. Y. & Betbeder, D. Airway delivery of peptides and proteins using nanoparticles. Biomaterials 34, 516\u2013525 (2013).","journal-title":"Biomaterials"},{"key":"12922_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature25164","volume":"553","author":"X Gao","year":"2018","unstructured":"Gao, X. et al. Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents. Nature 553, 217\u2013221 (2018).","journal-title":"Nature"},{"key":"12922_CR16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jbiotec.2015.04.024","volume":"208","author":"X Liang","year":"2015","unstructured":"Liang, X. et al. Rapid and highly efficient mammalian cell engineering via Cas9 protein transfection. J. Biotechnol. 208, 44\u201353 (2015).","journal-title":"J. Biotechnol."},{"key":"12922_CR17","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1002\/jps.22054","volume":"99","author":"DS Pisal","year":"2010","unstructured":"Pisal, D. S., Kosloski, M. P. & Balu-Iyer, S. V. Delivery of therapeutic proteins. J. Pharm. Sci. 99, 2557\u20132575 (2010).","journal-title":"J. Pharm. Sci."},{"key":"12922_CR18","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nrd.2016.280","volume":"16","author":"H Yin","year":"2017","unstructured":"Yin, H., Kauffman, K. J. & Anderson, D. G. Delivery technologies for genome editing. Nat. Rev. Drug Discov. 16, 387\u2013399 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"12922_CR19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nbt.3081","volume":"33","author":"JA Zuris","year":"2015","unstructured":"Zuris, J. A. et al. Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo. Nat. Biotechnol. 33, 73\u201380 (2015).","journal-title":"Nat. Biotechnol."},{"key":"12922_CR20","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00249-015-1025-x","volume":"44","author":"MS Venslauskas","year":"2015","unstructured":"Venslauskas, M. S. & Satkauskas, S. Mechanisms of transfer of bioactive molecules through the cell membrane by electroporation. Eur. Biophys. J. 44, 277\u2013289 (2015).","journal-title":"Eur. Biophys. J."},{"key":"12922_CR21","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1073\/pnas.1520244113","volume":"113","author":"M Wang","year":"2016","unstructured":"Wang, M. et al. Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles. Proc. Natl. Acad. Sci. USA 113, 2868\u20132873 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"12922_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/978-1-4939-7522-8_8","volume":"1715","author":"J de Melo","year":"2018","unstructured":"de Melo, J. & Blackshaw, S. In vivo electroporation of developing mouse retina. Methods Mol. Biol. 1715, 101\u2013111 (2018).","journal-title":"Methods Mol. Biol."},{"key":"12922_CR23","doi-asserted-by":"publisher","first-page":"e14467","DOI":"10.1371\/journal.pone.0014467","volume":"5","author":"EL Ayuni","year":"2010","unstructured":"Ayuni, E. L. et al. In vivo electroporation mediated gene delivery to the beating heart. PLoS ONE 5, e14467 (2010).","journal-title":"PLoS ONE"},{"key":"12922_CR24","doi-asserted-by":"publisher","first-page":"16010","DOI":"10.1074\/jbc.272.25.16010","volume":"272","author":"E Vives","year":"1997","unstructured":"Vives, E., Brodin, P. & Lebleu, B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272, 16010\u201316017 (1997).","journal-title":"J. Biol. Chem."},{"key":"12922_CR25","doi-asserted-by":"crossref","first-page":"10444","DOI":"10.1016\/S0021-9258(17)34080-2","volume":"269","author":"D Derossi","year":"1994","unstructured":"Derossi, D., Joliot, A. H., Chassaing, G. & Prochiantz, A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 269, 10444\u201310450 (1994).","journal-title":"J. Biol. Chem."},{"key":"12922_CR26","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.3390\/ph5111177","volume":"5","author":"A Erazo-Oliveras","year":"2012","unstructured":"Erazo-Oliveras, A., Muthukrishnan, N., Baker, R., Wang, T. Y. & Pellois, J. P. Improving the endosomal escape of cell-penetrating peptides and their cargos: strategies and challenges. Pharmaceuticals 5, 1177\u20131209 (2012).","journal-title":"Pharmaceuticals"},{"issue":"2","key":"12922_CR27","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3390\/ijms17020185","volume":"17","author":"Mie Kristensen","year":"2016","unstructured":"Kristensen, M., Birch, D. & Morck Nielsen, H. Applications and challenges for use of cell-penetrating peptides as delivery vectors for peptide and protein cargos. Int. J. Mol. Sci. 17, https:\/\/doi.org\/10.3390\/ijms17020185 (2016).","journal-title":"International Journal of Molecular Sciences"},{"key":"12922_CR28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1515\/bmc-2017-0023","volume":"8","author":"JC LeCher","year":"2017","unstructured":"LeCher, J. C., Nowak, S. J. & McMurry, J. L. Breaking in and busting out: cell-penetrating peptides and the endosomal escape problem. Biomol. Concepts 8, 131\u2013141 (2017).","journal-title":"Biomol. Concepts"},{"key":"12922_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/srep32301","volume":"6","author":"P Lonn","year":"2016","unstructured":"Lonn, P. et al. Enhancing endosomal escape for intracellular delivery of macromolecular biologic therapeutics. Sci. Rep. 6, 32301 (2016).","journal-title":"Sci. Rep."},{"key":"12922_CR30","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.bbamem.2006.02.021","volume":"1758","author":"H Sato","year":"2006","unstructured":"Sato, H. & Feix, J. B. Peptide-membrane interactions and mechanisms of membrane destruction by amphipathic alpha-helical antimicrobial peptides. Biochim. Biophys. Acta 1758, 1245\u20131256 (2006).","journal-title":"Biochim. Biophys. Acta"},{"key":"12922_CR31","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jconrel.2010.11.004","volume":"151","author":"AK Varkouhi","year":"2011","unstructured":"Varkouhi, A. K., Scholte, M., Storm, G. & Haisma, H. J. Endosomal escape pathways for delivery of biologicals. J. Control Rel. 151, 220\u2013228 (2011).","journal-title":"J. Control Rel."},{"key":"12922_CR32","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/cbic.200900527","volume":"11","author":"YJ Lee","year":"2010","unstructured":"Lee, Y. J., Erazo-Oliveras, A. & Pellois, J. P. Delivery of macromolecules into live cells by simple co-incubation with a peptide. Chembiochem 11, 325\u2013330 (2010).","journal-title":"Chembiochem"},{"key":"12922_CR33","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jconrel.2012.09.019","volume":"163","author":"F Salomone","year":"2012","unstructured":"Salomone, F. et al. A novel chimeric cell-penetrating peptide with membrane-disruptive properties for efficient endosomal escape. J. Control Rel. 163, 293\u2013303 (2012).","journal-title":"J. Control Rel."},{"key":"12922_CR34","doi-asserted-by":"publisher","first-page":"7923","DOI":"10.1039\/C7SC03918B","volume":"8","author":"I Lostale-Seijo","year":"2017","unstructured":"Lostale-Seijo, I., Louzao, I., Juanes, M. & Montenegro, J. Peptide\/Cas9 nanostructures for ribonucleoprotein cell membrane transport and gene edition. Chem. Sci. 8, 7923\u20137931 (2017).","journal-title":"Chem. Sci."},{"key":"12922_CR35","doi-asserted-by":"publisher","first-page":"e0195558","DOI":"10.1371\/journal.pone.0195558","volume":"13","author":"T Del\u2019Guidice","year":"2018","unstructured":"Del\u2019Guidice, T. et al. Membrane permeabilizing amphiphilic peptide delivers recombinant transcription factor and CRISPR-Cas9\/Cpf1 ribonucleoproteins in hard-to-modify cells. PLoS ONE 13, e0195558 (2018).","journal-title":"PLoS ONE"},{"key":"12922_CR36","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nchem.2779","volume":"9","author":"M Akishiba","year":"2017","unstructured":"Akishiba, M. et al. Cytosolic antibody delivery by lipid-sensitive endosomolytic peptide. Nat. Chem. 9, 751\u2013761 (2017).","journal-title":"Nat. Chem."},{"key":"12922_CR37","unstructured":"Guay, D., Del\u02bcGuidice, T. & Lepetit-Stoffaes, J. P. Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and\/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to same. US Patent 9,982,267 (2017)."},{"key":"12922_CR38","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1126\/science.1163600","volume":"321","author":"CS Rogers","year":"2008","unstructured":"Rogers, C. S. et al. Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. Science 321, 1837\u20131841 (2008).","journal-title":"Science"},{"key":"12922_CR39","doi-asserted-by":"publisher","first-page":"29ra31","DOI":"10.1126\/scitranslmed.3000928","volume":"2","author":"DA Stoltz","year":"2010","unstructured":"Stoltz, D. A. et al. Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth. Sci. Transl. Med. 2, 29ra31 (2010).","journal-title":"Sci. Transl. Med."},{"key":"12922_CR40","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1056\/NEJM199410133311503","volume":"331","author":"WE Highsmith","year":"1994","unstructured":"Highsmith, W. E. et al. A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations. N. Engl. J. Med. 331, 974\u2013980 (1994).","journal-title":"N. Engl. J. Med."},{"key":"12922_CR41","doi-asserted-by":"publisher","first-page":"L791","DOI":"10.1152\/ajpcell.1995.269.3.C791","volume":"269","author":"BR Stripp","year":"1995","unstructured":"Stripp, B. R., Maxson, K., Mera, R. & Singh, G. Plasticity of airway cell proliferation and gene expression after acute naphthalene injury. Am. J. Physiol. 269, L791\u2013L799 (1995).","journal-title":"Am. J. Physiol."},{"key":"12922_CR42","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/dvg.20335","volume":"45","author":"MD Muzumdar","year":"2007","unstructured":"Muzumdar, M. D., Tasic, B., Miyamichi, K., Li, L. & Luo, L. A global double-fluorescent Cre reporter mouse. Genesis 45, 593\u2013605 (2007).","journal-title":"Genesis"},{"key":"12922_CR43","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/s41551-017-0137-2","volume":"1","author":"K Lee","year":"2017","unstructured":"Lee, K. et al. Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair. Nat. Biomed. Eng. 1, 889\u2013901 (2017).","journal-title":"Nat. Biomed. Eng."},{"key":"12922_CR44","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.cell.2015.09.038","volume":"163","author":"B Zetsche","year":"2015","unstructured":"Zetsche, B. et al. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell 163, 759\u2013771 (2015).","journal-title":"Cell"},{"key":"12922_CR45","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.molcel.2017.06.035","volume":"67","author":"T Yamano","year":"2017","unstructured":"Yamano, T. et al. Structural basis for the canonical and non-canonical PAM recognition by CRISPR-Cpf1. Mol. Cell 67, 633\u2013645.e3 (2017).","journal-title":"Mol. Cell"},{"key":"12922_CR46","doi-asserted-by":"crossref","unstructured":"Cooney, A. L. et al. Lentiviral-mediated phenotypic correction of cystic fibrosis pigs. JCI Insight 1, e88730 (2016).","DOI":"10.1172\/jci.insight.88730"},{"key":"12922_CR47","unstructured":"Alton, E. W. et al. Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial. Lancet Respir. Med. 3, 684\u20136913 (2015)."},{"key":"12922_CR48","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1016\/j.celrep.2018.02.014","volume":"22","author":"JD Finn","year":"2018","unstructured":"Finn, J. D. et al. A single administration of CRISPR\/Cas9 lipid nanoparticles achieves robust and persistent in vivo genome editing. Cell Rep. 22, 2227\u20132235 (2018).","journal-title":"Cell Rep."},{"key":"12922_CR49","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jconrel.2018.07.001","volume":"285","author":"G Osman","year":"2018","unstructured":"Osman, G. et al. PEGylated enhanced cell penetrating peptide nanoparticles for lung gene therapy. J. Control Rel. 285, 35\u201345 (2018).","journal-title":"J. Control Rel."},{"key":"12922_CR50","doi-asserted-by":"publisher","first-page":"8720","DOI":"10.1073\/pnas.1502281112","volume":"112","author":"P Mastorakos","year":"2015","unstructured":"Mastorakos, P. et al. Highly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapy. Proc. Natl Acad. Sci. USA 112, 8720\u20138725 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"12922_CR51","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1089\/hum.2017.060","volume":"28","author":"Z Yan","year":"2017","unstructured":"Yan, Z. et al. Human bocavirus type-1 capsid facilitates the transduction of ferret airways by adeno-associated virus genomes. Hum. Gene Ther. 28, 612\u2013625 (2017).","journal-title":"Hum. Gene Ther."},{"key":"12922_CR52","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/gt.2011.55","volume":"18","author":"G McLachlan","year":"2011","unstructured":"McLachlan, G. et al. Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung. Gene Ther. 18, 996\u20131005 (2011).","journal-title":"Gene Ther."},{"key":"12922_CR53","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nbt1399","volume":"26","author":"SC Hyde","year":"2008","unstructured":"Hyde, S. C. et al. CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression. Nat. Biotechnol. 26, 549\u2013551 (2008).","journal-title":"Nat. Biotechnol."},{"key":"12922_CR54","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/mt.2008.96","volume":"16","author":"LA Davies","year":"2008","unstructured":"Davies, L. A. et al. Enhanced lung gene expression after aerosol delivery of concentrated pDNA\/PEI complexes. Mol. Ther. 16, 1283\u20131290 (2008).","journal-title":"Mol. Ther."},{"key":"12922_CR55","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1002\/stem.1150","volume":"30","author":"H Chen","year":"2012","unstructured":"Chen, H. et al. Airway epithelial progenitors are region specific and show differential responses to bleomycin-induced lung injury. Stem Cells 30, 1948\u20131960 (2012).","journal-title":"Stem Cells"},{"key":"12922_CR56","doi-asserted-by":"publisher","first-page":"12771","DOI":"10.1073\/pnas.0906850106","volume":"106","author":"JR Rock","year":"2009","unstructured":"Rock, J. R. et al. Basal cells as stem cells of the mouse trachea and human airway epithelium. Proc. Natl Acad. Sci. USA 106, 12771\u201312775 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"12922_CR57","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1172\/JCI57673","volume":"121","author":"HA Chapman","year":"2011","unstructured":"Chapman, H. A. et al. Integrin alpha6beta4 identifies an adult distal lung epithelial population with regenerative potential in mice. J. Clin. Invest 121, 2855\u20132862 (2011).","journal-title":"J. Clin. Invest"},{"key":"12922_CR58","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.cell.2008.10.020","volume":"135","author":"WW Shum","year":"2008","unstructured":"Shum, W. W. et al. Transepithelial projections from basal cells are luminal sensors in pseudostratified epithelia. Cell 135, 1108\u20131117 (2008).","journal-title":"Cell"},{"key":"12922_CR59","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/ng0992-21","volume":"2","author":"LG Johnson","year":"1992","unstructured":"Johnson, L. G. et al. Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis. Nat. Genet 2, 21\u201325 (1992).","journal-title":"Nat. Genet"},{"key":"12922_CR60","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/ng0295-126","volume":"9","author":"MJ Goldman","year":"1995","unstructured":"Goldman, M. J., Yang, Y. & Wilson, J. M. Gene therapy in a xenograft model of cystic fibrosis lung corrects chloride transport more effectively than the sodium defect. Nat. Genet 9, 126\u2013131 (1995).","journal-title":"Nat. Genet."},{"key":"12922_CR61","doi-asserted-by":"publisher","first-page":"L1123","DOI":"10.1152\/ajplung.00049.2005","volume":"289","author":"SL Farmen","year":"2005","unstructured":"Farmen, S. L. et al. Gene transfer of CFTR to airway epithelia: low levels of expression are sufficient to correct Cl\u2212 transport and overexpression can generate basolateral CFTR. Am. J. Physiol. Lung Cell Mol. Physiol. 289, L1123\u2013L1130 (2005).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"12922_CR62","doi-asserted-by":"publisher","first-page":"e1000155","DOI":"10.1371\/journal.pbio.1000155","volume":"7","author":"L Zhang","year":"2009","unstructured":"Zhang, L. et al. CFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fibrosis airway epithelium. PLoS Biol. 7, e1000155 (2009).","journal-title":"PLoS Biol."},{"key":"12922_CR63","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1165\/rcmb.2008-0018OC","volume":"40","author":"L Dannhoffer","year":"2009","unstructured":"Dannhoffer, L., Blouquit-Laye, S., Regnier, A. & Chinet, T. Functional properties of mixed cystic fibrosis and normal bronchial epithelial cell cultures. Am. J. Respir. Cell Mol. Biol. 40, 717\u2013723 (2009).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"12922_CR64","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli, N. M. et al. Programmable base editing of A*T to G*C in genomic DNA without DNA cleavage. Nature 551, 464\u2013471 (2017).","journal-title":"Nature"},{"key":"12922_CR65","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1021\/acschembio.7b00710","volume":"13","author":"AC Komor","year":"2018","unstructured":"Komor, A. C., Badran, A. H. & Liu, D. R. Editing the genome without double-stranded DNA breaks. ACS Chem. Biol. 13, 383\u2013388 (2018).","journal-title":"ACS Chem. Biol."},{"key":"12922_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05641-3","volume":"9","author":"HM Park","year":"2018","unstructured":"Park, H. M. et al. Extension of the crRNA enhances Cpf1 gene editing in vitro and in vivo. Nat. Commun. 9, 3313 (2018).","journal-title":"Nat. Commun."},{"key":"12922_CR67","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nbt.3437","volume":"34","author":"JG Doench","year":"2016","unstructured":"Doench, J. G. et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat. Biotechnol. 34, 184\u2013191 (2016).","journal-title":"Nat. Biotechnol."},{"key":"12922_CR68","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1021\/acssynbio.6b00343","volume":"6","author":"R Chari","year":"2017","unstructured":"Chari, R., Yeo, N. C., Chavez, A. & Church, G. M. sgRNA Scorer 2.0: a species-independent model to predict CRISPR\/Cas9 activity. ACS Synth. Biol. 6, 902\u2013904 (2017).","journal-title":"ACS Synth. Biol."},{"key":"12922_CR69","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41587-018-0011-0","volume":"37","author":"BP Kleinstiver","year":"2019","unstructured":"Kleinstiver, B. P. et al. Engineered CRISPR-Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing. Nat. Biotechnol. 37, 276\u2013282 (2019).","journal-title":"Nat. Biotechnol."},{"key":"12922_CR70","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s000110050114","volume":"46","author":"LB Soong","year":"1997","unstructured":"Soong, L. B., Ganz, T., Ellison, A. & Coughey, G. H. Purification and characterization of defensins from cystic fibrosis sputum. Inflamm. Res. 46, 98\u2013102 (1997).","journal-title":"Inflamm. Res."},{"key":"12922_CR71","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41591-018-0326-x","volume":"25","author":"CT Charlesworth","year":"2019","unstructured":"Charlesworth, C. T. et al. Identification of preexisting adaptive immunity to Cas9 proteins in humans. Nat. Med. 25, 249\u2013254 (2019).","journal-title":"Nat. Med."},{"key":"12922_CR72","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/ph6020184","volume":"6","author":"AA Keller","year":"2013","unstructured":"Keller, A. A. et al. Relationships between cargo, cell penetrating peptides and cell type for uptake of non-covalent complexes into live cells. Pharmaceuticals 6, 184\u2013203 (2013).","journal-title":"Pharmaceuticals"},{"key":"12922_CR73","unstructured":"Karp, P. H. et al. in Epithelial Cell Culture Protocols Vol. 188 (ed. Wise, C.) 115\u2013137 (Humana Press, 2002)."},{"key":"12922_CR74","doi-asserted-by":"publisher","first-page":"12818","DOI":"10.1128\/JVI.79.20.12818-12827.2005","volume":"79","author":"PL Sinn","year":"2005","unstructured":"Sinn, P. L., Burnight, E. R., Hickey, M. A., Blissard, G. W. & McCray, P. B. Jr. Persistent gene expression in mouse nasal epithelia following feline immunodeficiency virus-based vector gene transfer. J. Virol. 79, 12818\u201312827 (2005).","journal-title":"J. Virol."},{"key":"12922_CR75","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/978-1-60761-753-2_15","volume":"649","author":"DY Guschin","year":"2010","unstructured":"Guschin, D. Y. et al. A rapid and general assay for monitoring endogenous gene modification. Methods Mol. Biol. 649, 247\u2013256 (2010).","journal-title":"Methods Mol. Biol."},{"key":"12922_CR76","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/s41374-018-0057-0","volume":"98","author":"DK Meyerholz","year":"2018","unstructured":"Meyerholz, D. K. & Beck, A. P. Principles and approaches for reproducible scoring of tissue stains in research. Lab. Invest. 98, 844\u2013855 (2018).","journal-title":"Lab. Invest."},{"key":"12922_CR77","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/infdis\/jiv499","volume":"213","author":"K Li","year":"2015","unstructured":"Li, K. et al. Middle East respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4. J. Infect. Dis. 213, 712\u2013722 (2015).","journal-title":"J. Infect. Dis."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-12922-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-12922-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-12922-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T01:48:45Z","timestamp":1671241725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-12922-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,28]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["12922"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-12922-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,28]]},"assertion":[{"value":"4 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.B.M. is a founder of and holds equity in Talee Bio. D.G. holds equity in Feldan Therapeutics. D.G., T.D., and J.-P.L.-S. hold employee stock options from Feldan Therapeutics. V.T., S.H., A.-M.D., T.D., J.-P.L.-S., X.B., and D.G. are employees of Feldan Therapeutics. D.G., T.D., and J.-P.L.-S. are inventors of US Patents No. 9,738,687 and 9,982,267 related to this technology and assigned to Feldan Bio Inc. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4906"}}